Olfax Medical

Olfax Medical is a healthcare technology company focused on revolutionizing the treatment of neurological and central nervous system (CNS) disorders through superior drug delivery. The company has developed a proprietary nose-to-brain delivery platform that utilizes the olfactory pathway to bypass the blood-brain barrier, which is a significant hurdle for many CNS therapeutics. Their device is designed to deposit medication precisely in the upper nasal cavity, allowing for rapid and direct transport to the brain. This technology aims to enhance the bioavailability of drugs while minimizing systemic exposure and side effects. Olfax Medical is currently targeting high-impact indications such as migraine and chronic pain, where rapid onset and targeted delivery are critical. The company is a spin-out from Colorado State University and leverages advanced aerosol science to optimize its delivery systems.